Imexpharm Market Cap

Imexpharm has a market cap or net worth of 7.18 trillion as of May 22, 2026. Its market cap has increased by 7.24% in one year.

Market Cap

7.18T

Enterprise Value

6.92T

Revenue

2.39T

Ranking

n/a

PE Ratio

23.09

Stock Price

46,650.00

Market Cap Chart

Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 7.18T, an increase of 547.95%. That is a compound annual growth rate of 10.25%.

Market Cap History

Date	Market Cap	% Change
May 22, 2026	7.18T	-11.14%
Dec 31, 2025	8.09T	11.70%
Dec 31, 2024	7.24T	82.69%
Dec 29, 2023	3.96T	-1.28%
Dec 30, 2022	4.01T	-22.62%
Dec 31, 2021	5.19T	38.19%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
DHG Pharmaceutical JSC	12.42T
Traphaco JSC	3.27T
Cuu Long Pharmaceutical JSC	2.83T
Domesco Medical Import - Export Joint-Stock	2.05T
OPC Pharmaceutical JSC	1.51T
Vidipha Central Pharmaceutical JSC	1.23T
Ben Tre Pharmaceutical JSC	274.59B
Mediplantex National Pharmaceutical JSC	228.34B

Market Cap Rankings